Amed Co., Ltd.

As of December 31, 2025, Amed Co., Ltd. carries a market capitalization of 867.00M, placing it among publicly traded companies globally. Its enterprise value stands at 1.34B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Amed Co., Ltd. has 30.00M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Amed Co., Ltd. maintains a current ratio of 1.21, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on July 30, 2026, Amed Co., Ltd.'s stock has declined approximately 63.09% over the past 52 weeks. The 50-day moving average sits at 16.88, while the 200-day moving average is 24.42.

As of December 31, 2025, Amed Co., Ltd. holds 78.66M in cash and equivalents against 550.86M in total debt, resulting in a net debt position of 454.39M. Total book value stands at 397.03M, with working capital of 90.16M providing operational flexibility.

Amed Co., Ltd.'s most recent stock split took place on August 24, 2023 with a 4:5 split ratio.